E-LIB Suche - Ergebnisse für: Lopez-Brea, Marta

1

The S-REAL study: Spanish real-world data on unresectable s..:

Gómez Rueda, Ana ; Taus, Álvaro ; Álvarez Álvarez, Rosa...
Clinical and Translational Oncology. 26 (2024) 7 - p. 1779-1789 , 2024

Link: https://doi.org/10.1007/..

2

Neoadjuvant chemotherapy with dose-dense MVAC in muscle-inv..:

Serrano, Marina ; Muñoz-Unceta, Nerea ; Alonso, Lucía Andrea...
Clinical and Translational Oncology. 26 (2023) 2 - p. 549-553 , 2023

Link: https://doi.org/10.1007/..

3

Cost-effectiveness of atezolizumab versus pembrolizumab as ..:

Isla, Dolores ; Lopez-Brea, Marta ; Espinosa, María...
Cost Effectiveness and Resource Allocation. 21 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

4

Alectinib after failure to crizotinib in patients with ALK-..:

Bernabé-Caro, Reyes ; Garrido, Pilar ; García-Campelo, Rosario...
Oncotarget. 13 (2022) 1 - p. 812-827 , 2022

Link: https://doi.org/10.18632..

5

Circulating Levels of the Interferon-γ-Regulated Chemokines..:

Esteban, Emilio ; Exposito, Francisco ; Crespo, Guillermo...
Cancers. 13 (2021) 11 - p. 2849 , 2021

Link: https://doi.org/10.3390/..

6

PD-L1 Inhibitors as Monotherapy for the First-Line Treatmen..:

García Campelo, María Rosario ; Arriola, Edurne ; Campos Balea, Begoña...
Journal of Clinical Medicine. 10 (2021) 19 - p. 4583 , 2021

Link: https://doi.org/10.3390/..

7

Consensus Recommendations from the Spanish Germ Cell Cancer..:

González-Billalabeitia, Enrique ; Sepúlveda, Juan Manuel ; Maroto, Pablo...
European Urology Focus. 3 (2017) 2-3 - p. 280-286 , 2017

Link: https://doi.org/10.1016/..

8

Impact on clinical practice of the implementation of guidel..:

Lainez, Nuria ; García-Donas, Jesús ; Esteban, Emilio...
BMC Cancer. 16 (2016) 1 - p. , 2016

Link: https://doi.org/10.1186/..

9

Cost-effectiveness evaluation of sunitinib as first-line ta..:

Calvo Aller, Emiliano ; Maroto, Pablo ; Kreif, Noémi...
Clinical and Translational Oncology. 13 (2011) 12 - p. 869-877 , 2011

Link: https://doi.org/10.1007/..

10

SEOM guidelines for the management of non-small-cell lung c..:

SEOM Guidelines Working Group ; Felip, Enriqueta ; Garrido, Pilar...
Clinical and Translational Oncology. 11 (2009) 5 - p. 284-289 , 2009

Link: https://doi.org/10.1007/..

11

Randomized phase II study of cisplatin and 5-FU continuous ..:

Rivera, Fernando ; Vega-Villegas, M. Eugenia ; López-Brea, Marta...
Cancer Chemotherapy and Pharmacology. 62 (2007) 2 - p. 253-261 , 2007

Link: https://doi.org/10.1007/..

12

P-220 Polymorphisms in DNA repair genes and survival in cis..:

Isla, Dolores ; Queralt, Cristina ; Alonso, Guillermo...
Lung Cancer. 41 (2003) - p. S147 , 2003

Link: https://doi.org/10.1016/..

13

P-203 SLCG 9901: phase II trial with cisplatin (cis), gemci..:

Garrido, Pilar ; Barceló, Ramón ; Artal, Angel...
Lung Cancer. 41 (2003) - p. S142 , 2003

Link: https://doi.org/10.1016/..

14

Long term results of a phase II trial of Induction Chemothe..:

Rivera, Fernando ; Vega-Villegas, María E ; López-Brea, Marta F....
Clinical and Translational Oncology. 9 (2007) 1 - p. 40-47 , 2007

Link: https://doi.org/10.1007/..

15

Long term results of a phase II trial of Induction Chemothe..:

Rivera, Fernando ; Vega-Villegas, María E ; López-Brea, Marta F....
Clinical and Translational Oncology. 9 (2007) 3 - p. 202-202 , 2007

Link: https://doi.org/10.1007/..